Allan Kermode

27PUBLICATIONS

131CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNeurology and neuromuscular diseasesBiomechanicsGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (27)

Sort by Publication Date:

|May 20, 2026

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

|Apr 01, 2026

Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Andrea Surcinelli, Tomas Kalincik, Izanne Roos

|Mar 05, 2026

Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Pakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt

|Feb 25, 2026

Clinician-led, single-blind, randomised controlled trial evaluating the efficacy of a high-intensity resistance and impact training intervention for improving health-related quality of life in people with multiple sclerosis: protocol for STRONG-MS.

Lisa Grech, Belinda Beck, David Scott

|Jul 22, 2025

COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection.

Avani Yeola, Samuel Houston, Anupriya Aggarwal

|Jul 07, 2025

Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024).

Vilija G Jokubaitis, Raed Alroughani, Ayse Altintas

Pageof 5

Frequent Collaborators

Tomas Kalincik

Anneke van der Walt

Raed Alroughani

Helmut Butzkueven

Vilija G Jokubaitis

Michael H Barnett

Jeannette Lechner-Scott

4 joint publications

Pamela McCombe

4 joint publications

Mastura Monif

4 joint publications

Wei Qiu

Frequent Collaborators

Tomas Kalincik

Anneke van der Walt

Raed Alroughani

Helmut Butzkueven